The finding will likely help physicians develop targeted therapies for future COVID patients.

For some patients, adding aspirin to a direct oral anticoagulant rarely adds up, a new study finds.

A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.

Despite efforts to improve the standard of care for children with sickle cell disease, the nation falls short, says pediatrician

A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.

A Michigan Medicine professor and a U-M medical student created an app to help patients manage HHT, a systemic blood vessel disorder characterized by excessive nose bleeding.